Literature DB >> 15183147

Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.

Wendy B Bernstein1, Josephine H Cox, Naomi E Aronson, LaRee Tracy, Katia Schlienger, Silvia Ratto-Kim, Robin Garner, Julio Cotte, Zhaohui Zheng, Lena Winestone, Caroline Liebig, Lynee M Galley, Mark Connors, Deborah L Birx, Richard G Carroll, Bruce L Levine.   

Abstract

We have previously shown that adoptive transfer of in vitro CD3/CD28 activated autologous CD4(+) T cells results in increased CD4 counts and CD4/CD8 ratios in HIV+ subjects. In this report, analysis of variable beta (Vbeta) chain T cell receptor (TCR) repertoire showed that CD3/CD28 stimulation was able to increase polyclonality within skewed spectra types in vitro. In vivo, two of eight subjects showed increase in TCR diversity and importantly, in no subject did a highly skewed in vivo repertoire emerge. Measurement of proliferative response to alloantigen showed increases following infusions. Response to pharmacological stimulus and lectin via Interferon-gamma ELISpot assay showed increases in a subset of subjects following infusions. However, interferon-gamma response to HIV antigens and peptides declined concurrent with stable or diminishing latent infectious viral load in CD4(+) T cells. These data provide further evidence that adoptive transfer of activated autologous CD4(+) T cells can augment the immune system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183147     DOI: 10.1016/j.clim.2004.03.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.

Authors:  D L DiGiusto; L J N Cooper
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

2.  Toward synthetic biology with engineered T cells: a long journey just begun.

Authors:  Carl H June
Journal:  Hum Gene Ther       Date:  2014-09       Impact factor: 5.695

Review 3.  The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19.

Authors:  Peter Braendstrup; Bruce L Levine; Marco Ruella
Journal:  Cytotherapy       Date:  2020-02-01       Impact factor: 5.414

4.  Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28.

Authors:  Jacalyn Rosenblatt; Zekui Wu; Baldev Vasir; Corrine Zarwan; Richard Stone; Heidi Mills; Thea Friedman; Panagiotis A Konstantinopoulos; Dimitrios Spentzos; Musie Ghebremichael; Kristen Stevenson; Donna Neuberg; James D Levine; Robin Joyce; Dimitrios Tzachanis; Vassiliki Boussiotis; Donald Kufe; David Avigan
Journal:  J Immunother       Date:  2010 Feb-Mar       Impact factor: 4.456

5.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

Review 6.  Pirate primates in uncharted waters: lymphocyte transfers in unrelated, MHC-matched macaques.

Authors:  Benjamin J Burwitz; Justin M Greene; David H O'Connor
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

7.  Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.

Authors:  Baldev Vasir; Zekui Wu; Keith Crawford; Jacalyn Rosenblatt; Corrine Zarwan; Adam Bissonnette; Donald Kufe; David Avigan
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 8.  Current translational and clinical practices in hematopoietic cell and gene therapy.

Authors:  David L Digiusto; Hans-Peter Kiem
Journal:  Cytotherapy       Date:  2012-08       Impact factor: 5.414

9.  Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaques.

Authors:  Justin M Greene; Benjamin J Burwitz; Alex J Blasky; Teresa L Mattila; Jung Joo Hong; Eva G Rakasz; Roger W Wiseman; Kim J Hasenkrug; Pamela J Skinner; Shelby L O'Connor; David H O'Connor
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.